Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Obstetrics

Does Gestational Diabetes Cause Holoprosencephaly?

At a Glance

Gestational diabetes does not cause holoprosencephaly (HPE) because the fetal brain divides between weeks 4 and 6 of pregnancy, long before gestational diabetes develops. While pre-existing diabetes is a risk factor, the overall chance of HPE remains very low.

If you had gestational diabetes during your pregnancy and your child was diagnosed with holoprosencephaly (HPE), the most important thing for you to know is that your gestational diabetes did not cause your baby’s condition. Maternal guilt is a heavy and common burden for parents of children with HPE. However, a metabolic condition that develops later in pregnancy cannot alter brain structures that formed during the earliest weeks.

The Timing of Brain Development vs. Gestational Diabetes

To understand why gestational diabetes does not cause HPE, it is helpful to look at the timeline of fetal development.

Holoprosencephaly occurs when the embryonic forebrain (the prosencephalon) fails to completely divide into right and left hemispheres [1][2]. This critical step of brain development is known as cleavage—imagine a single, round structure that needs to split down the middle to form two separate halves. This process happens extremely early in pregnancy, primarily between the 4th and 6th weeks of gestation [1][3].

Gestational diabetes, on the other hand, typically develops later in pregnancy and is usually diagnosed during standard screening between 24 and 28 weeks [4][5]. By the time gestational diabetes alters blood sugar levels in the mother’s body, the window for the baby’s forebrain to divide has already closed months prior. Because of this timeline, gestational diabetes is biologically incapable of causing HPE.

Pre-Existing Maternal Diabetes as a Risk Factor

You may have read online or in medical records that “maternal diabetes” is a risk factor for holoprosencephaly. This frequently causes confusion and self-blame among parents. When medical literature refers to this risk, it is specifically talking about pre-gestational diabetes—meaning Type 1 or Type 2 diabetes that existed before the pregnancy began [6][7].

When a mother has pre-existing, suboptimally controlled diabetes during the very first weeks of pregnancy, elevated blood sugar is present exactly when the fetal brain is beginning to form. Studies show that pre-gestational diabetes is a non-genetic risk factor that can increase the chance of HPE [8].

If you had pre-existing diabetes, it is crucial to know that the absolute risk of your baby developing HPE remains extremely low. The vast majority of mothers with diabetes have babies without HPE. Furthermore, even in cases of pre-existing diabetes, it is rarely the sole cause. HPE is a complex condition, usually resulting from a combination of genetic factors and specific, rare environmental factors [9][10]. (In this context, “environmental factors” refers to complex interactions like genetic mutations combined with rare high-risk medications or severe infections—not normal daily activities, standard diets, or household cleaning products.)

Letting Go of the Guilt

Gestational diabetes has a distinctly different risk profile than pre-existing diabetes, and it is associated with far fewer types of congenital anomalies [8]. If your diabetes developed during pregnancy rather than existing beforehand, it was not present when the brain was undergoing cleavage.

There is nothing you could have done differently to change the way the embryonic brain divided during those first few weeks. As you navigate your child’s care, understanding this timeline can help you shift your focus from questioning the past to working with your care team to advocate for your child’s future.

Common questions in this guide

Did my gestational diabetes cause my baby's holoprosencephaly?
No, gestational diabetes cannot cause holoprosencephaly. The critical process of the embryonic brain dividing into two halves happens extremely early, between the 4th and 6th weeks of pregnancy. This is months before gestational diabetes typically develops and affects maternal blood sugar.
Why do some medical records say maternal diabetes is a risk factor for HPE?
When medical literature mentions maternal diabetes as a risk factor for HPE, it specifically refers to pre-existing Type 1 or Type 2 diabetes. Having elevated blood sugar during the very first weeks of pregnancy can increase the risk, but the condition is rarely the sole cause.
Should we see a geneticist to find out what actually caused the holoprosencephaly?
Yes, consulting a geneticist or genetic counselor is highly recommended. Because holoprosencephaly is a complex condition usually caused by genetic factors, a specialist can help investigate the actual underlying cause of your child's diagnosis.
If I have pre-existing diabetes, will my baby definitely develop HPE?
No, the absolute risk of your baby developing HPE remains extremely low, and the vast majority of mothers with diabetes have babies without the condition. Holoprosencephaly typically results from a combination of genetic factors and specific rare environmental triggers.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my history of gestational diabetes, are there any specific metabolic or growth patterns we should monitor for my child going forward?
  2. 2.Since gestational diabetes did not cause the HPE, would we benefit from a referral to a genetic counselor to investigate the actual underlying cause?
  3. 3.Based on the timing of my child's diagnosis and the specific type of HPE, what does this mean for our long-term care plan?
  4. 4.If we plan to have more children, how should my future pregnancies be monitored given this diagnosis and my history of gestational diabetes?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Disorders of Ventral Induction/Spectrum of Holoprosencephaly.

    Calloni SF, Caschera L, Triulzi FM

    Neuroimaging clinics of North America 2019; (29(3)):411-421 doi:10.1016/j.nic.2019.03.003.

    PMID: 31256862
  2. 2

    Mutations in phospholipase C eta-1 (PLCH1) are associated with holoprosencephaly.

    Drissi I, Fletcher E, Shaheen R, et al.

    Journal of medical genetics 2022; (59(4)):358-365 doi:10.1136/jmedgenet-2020-107237.

    PMID: 33820834
  3. 3

    Holoprosencephaly spectrum: an up-to-date overview of classification, genetics and neuroimaging.

    Gomez GD, Corrêa DG, Trapp B, et al.

    Japanese journal of radiology 2025; (43(1)):13-31 doi:10.1007/s11604-024-01655-8.

    PMID: 39259418
  4. 4

    The Effects of Gestational Diabetes on Fetus: A Surveillance Study.

    Ejaz Z, Azhar Khan A, Sebghat Ullah S, et al.

    Cureus 2023; (15(2)):e35103 doi:10.7759/cureus.35103.

    PMID: 36938248
  5. 5

    Relationship between C-reactive Protein and Screening Test Results of Gestational Diabetes in Pregnant Women Referred to Health Centers in Isfahan in 2013-2014.

    Kianpour M, Saadatmand F, Nematbakhsh M, Fahami F

    Iranian journal of nursing and midwifery research 2019; (24(5)):360-364 doi:10.4103/ijnmr.IJNMR_352_14.

    PMID: 31516522
  6. 6

    Are the prevalence of Trisomy 13 and the incidence of severe holoprosencephaly increasing in Africa?

    Okoye JO, Ngokere AA

    Prenatal diagnosis 2020; (40(12)):1616-1617 doi:10.1002/pd.5777.

    PMID: 32715507
  7. 7

    Nongenetic risk factors for holoprosencephaly: An updated review of the epidemiologic literature.

    Summers AD, Reefhuis J, Taliano J, Rasmussen SA

    American journal of medical genetics. Part C, Seminars in medical genetics 2018; (178(2)):151-164 doi:10.1002/ajmg.c.31614.

    PMID: 29761639
  8. 8

    Risks of specific congenital anomalies in offspring of women with diabetes: A systematic review and meta-analysis of population-based studies including over 80 million births.

    Zhang TN, Huang XM, Zhao XY, et al.

    PLoS medicine 2022; (19(2)):e1003900 doi:10.1371/journal.pmed.1003900.

    PMID: 35104296
  9. 9

    Concepts in Multifactorial Etiology of Developmental Disorders: Gene-Gene and Gene-Environment Interactions in Holoprosencephaly.

    Lo HF, Hong M, Krauss RS

    Frontiers in cell and developmental biology 2021; (9()):795194 doi:10.3389/fcell.2021.795194.

    PMID: 35004690
  10. 10

    Identifying environmental risk factors and gene-environment interactions in holoprosencephaly.

    Addissie YA, Troia A, Wong ZC, et al.

    Birth defects research 2021; (113(1)):63-76 doi:10.1002/bdr2.1834.

    PMID: 33111505

This page provides educational information about holoprosencephaly and maternal diabetes risk factors. It does not replace professional medical advice or genetic counseling regarding your child's specific diagnosis.

Get notified when new evidence is published on Holoprosencephaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.